The board meeting for Pharming Grp N.V. (ADR) is scheduled for today, for the purpose of Pharming Group Fourth Quarter Earnings Results for 2025See details
Pharming Grp N.V. (ADR) has a share price target of US$ 34, revenue growth forecast of 33.4%, and profit growth estimate of 143.3% for FY25, based on top 3 analyst calls.